ITM Isotope Technologies Munich US Headquarters in Princeton, NJ

https://www.itm-radiopharma.com

In April 2023 ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, announced that the company has opened its U.S. headquarters in Princeton, New Jersey and appointed Roger Estafanos as U.S. General Manager. Mr. Estafanos brings a wealth of experience from both the radiopharmaceutical and pharmaceutical industries including being one of the first leaders of the US division of Advanced Accelerator Applications (AAA), a Novartis company. His arrival builds on ITM’s appointment of key hires to its U.S. leadership team in 2022. Establishing the headquarters in Princeton strengthens ITM’s ongoing expansion of its U.S. business, including the sales and marketing of the company’s therapeutic and diagnostic radioisotopes, while preparing for potential market registration of its targeted radiopharmaceutical pipeline product candidates currently in development. *

	Start	2023-04-17 established
	Group	ITM (Group)
	Industry	RADIOPHARMACEUTICAL (RPT)
	Industry 2	ITM-11 (n.c.a. 177Lu-edotreotide)
	Person	Estafanos, Roger (ITM 202304– General Manager US before Advanced Accelerator Applications)

	Region	Princeton, NJ
	Country	United States (USA)
	City	n. a. Princeton, NJ
		Address record changed: 2023-04-18

Basic data	Employees	n. a.

		* Document for »About Section«: ITM Isotope Technologies Munich SE. (4/17/23). "Press Release: ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey". Garching & Princeton, NJ.

		Record changed: 2024-06-10